CGAs can regulate NF-κB and PPARα pathways, lower HIF-1α expression, and suppress cardiac apoptotic signaling, thus executing beneficial effects against cardiac hypertrophy and heart failure (HF) [2]. This evidence concerns the gene PPARA and cardiac hypertrophy.